TRPC5 and breast cancer: TRPC5 and the multi-drug resistance (MDR) transporter, p-glycoprotein, were found to be up-regulated in the MCF-7 breast cancer cell line following repeated exposure to adriamycin until development of drug resistance (Ma et al.